AGM/EGMMay 21, 2026, 04:24 PM
TransMedics Shareholders Elect Directors, Approve Stock Plan
AI Summary
TransMedics Group, Inc. held its 2026 Annual Meeting of Shareholders on May 20, 2026. Shareholders elected all eight director nominees, including Waleed Hassanein, M.D. and Stephanie Lovell, to serve until the 2027 Annual Meeting. Additionally, shareholders approved the compensation of named executive officers on an advisory basis and ratified the amendment to the 2019 Stock Incentive Plan. PricewaterhouseCoopers LLP was also ratified as the independent auditor for the fiscal year ending December 31, 2026.
Key Highlights
- All eight director nominees, including Waleed Hassanein, M.D. and Stephanie Lovell, were elected to the Board.
- Shareholders approved, on a non-binding advisory basis, the compensation paid to named executive officers with 22,871,647 votes For.
- The amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan was approved with 17,265,369 votes For.
- PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2026 with 28,030,696 votes For.
- Waleed Hassanein, M.D. received 23,925,335 votes For his re-election as director.
- Stephanie Lovell received the highest votes For re-election with 23,932,921.
- Edward M. Basile received 22,395,787 votes For his re-election as director.
Price Impact
More from TMDX